LUMCi048CTRL-A, 48CTRL-A, 48CTRL-3
LUMCi048-A
General
Cell Line |
|
hPSCreg name | LUMCi048-A |
Cite as: | LUMCi048-A (RRID:CVCL_C1UF) |
Alternative name(s) |
LUMCi048CTRL-A, 48CTRL-A, 48CTRL-3
|
Cell line type | Human induced pluripotent stem cell (hiPSC) |
Similar lines |
LUMCi048-B (48CTRL-B, LUMCi048CTRL-B, 48CTRL-6) LUMCi048-C (LUMCi048CTRL-C, 48CTRL-C, 48CTRL-8) |
Last update | 1st March 2024 |
User feedback | |
Provider |
|
Generator | Leiden University Medical Center (LUMC) |
Owner | Leiden University Medical Center (LUMC) |
Distributors | |
Derivation country | Netherlands |
External Databases |
|
BioSamples | SAMEA12121561 |
Cellosaurus | CVCL_C1UF |
Wikidata | Q114311892 |
General Information |
|
* Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: not allowed
Commercial use: allowed
|
Donor Information
General Donor Information |
|
Sex | female |
Age of donor (at collection) | 60-64 |
Ethnicity | Caucasian |
Phenotype and Disease related information (Donor) |
|
Diseases | No disease was diagnosed.
|
Karyotyping (Donor) |
|
Has the donor karyotype been analysed? |
Yes
46 XX
Karyotyping method:
Molecular karyotyping by SNP array
http:// |
Other Genotyping (Donor) |
|
Is there genome-wide genotyping or functional data available? |
No
|
Donor Relations |
|
Other cell lines of this donor | |
External Databases (Donor) |
|
BioSamples | SAMEA12983518 |
Ethics
Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? | Yes |
Was the consent voluntarily given? | Yes |
Has the donor been informed that participation will not directly influence their personal treatment? | Yes |
Can you provide us with a copy of the Donor Information Sheet provided to the donor? | Yes |
Do you (Depositor/Provider) hold the original Donor Consent Form? | No |
If you do not hold the Donor Consent Form, do you know who does? | Yes |
Please provide the contact information |
Rich Horgan |
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. | pseudonymised |
Does consent explicitly allow the derivation of pluripotent stem cells? | Yes |
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? | No |
How may genetic information associated with the cell line be accessed? | Controlled Access |
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? | No |
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | Yes |
Name of accrediting authority involved? | UMass Medical Center Memorial Campus Ethical committee |
Approval number | CR00473248 |
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
hIPSC Derivation
General |
|
Source cell type |
A fibroblast of skin.
|
Age of donor (at collection) | 60-64 |
Reprogramming method |
|
Vector type | Non-integrating |
Vector | Single‑Stranded RNA Replicon Vector |
Is reprogramming vector detectable? |
Unknown |
Vector free reprogramming |
|
Type of used vector free reprogramming factor(s) |
mRNA
|
Other |
|
Derived under xeno-free conditions |
Unknown |
Derived under GMP? |
Unknown |
Available as clinical grade? |
Unknown |
Culture Conditions
Surface coating | Matrigel/Geltrex |
Feeder cells |
No |
Passage method |
Enzyme-free cell dissociation
ReLeSR
|
CO2 Concentration | 5 % |
Medium |
mTeSR™ 1
|
Characterisation
Analysis of Undifferentiated Cells
Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
SSEA-4 |
Yes |
|
||||
NANOG |
Yes |
|
||||
POU5F1 (OCT-4) |
Yes |
|
Differentiation Potency
Genotyping
Karyotyping (Cell Line) |
|
Has the cell line karyotype been analysed? |
Yes
46 XX
Karyotyping method:
Molecular karyotyping by SNP array
http:// |
Other Genotyping (Cell Line) |
Login to share your feedback, experiences or results with the research community.